02.12.26 -- What CROs Do Right Isn't Always Obvious To Research Sites

Hilary Marston discusses how staffing losses at FDA are uneven across divisions, with particularly heavy impact in innovative areas like AI and real-world evidence.

Early medical assessment reduces risk, improves patient selection, and avoids trial delays. Learn how starting early boosts compliance, speeds timelines, and protects participants and results.

Watch as this expert panel explores how Australia, Taiwan, and South Korea provide a strategic advantage in conducting early, mid, and late-phase oncology trials.

This 2024 Industry Pages report provides an in-depth examination of the Central and Eastern European (CEE) clinical trial strategy, highlighting its pivotal role in global drug development.

Review 2025’s gap between artificial intelligence discovery and trial execution, highlighting legislative and FDA shifts to help sponsors operationalize participant experience for 2026.

In this presentation, Precision’s Chief Medical Officer and former FDA Director, Division of Oncology 2, Harpreet Singh, MD, breaks down three FDA approvals from last year that are impacting 2026.

Choosing the right bioanalysis CRO is vital to avoid costly delays. Sponsors need evaluation strategies that prioritize proven quality, predictable timelines, and submission-ready data.

Philip Johnston, Clinical Supply Lead at Catalent Pharma Solutions, talks about best practices for efficient and timely clinical resupply and helping sponsors execute supply chain strategies.

Explore how collaborative problem-solving and trust-based partnerships help study teams manage complexity, adapt to change, and align priorities for better outcomes across sponsors, CROs, and sites.

Recovering lost clinical trials is an art. See how we're able to triage your study’s problem areas, build recovery strategies to address your drifting trial’s performance, and deliver results.

Automate RFPs, select the right vendors, and manage them financially — track change orders, monitor projections vs. actuals, and drive smarter decisions with advanced analytics.

Beyond basic storage, our comprehensive services deliver fully compliant, state-of-the-art environments where samples are meticulously cataloged, tracked, and maintained with precision.